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The Life Sciences Research Office (LSRO) ofthe Fed-
eration ofAmerican Societies for Experimental Biology
(FASEB), provides scientific assessments of topics in
the biomedical sciences. Reports are based upon com-
prehensive literature reviews and the scientific opinions
ofknowledgeableinvestigators engaged inspecificareas
of biology and medicine.
The extrapolation of data on carcinogenic responses
of animal models to estimations of risk of cancer in hu-
mans is a complex and controversial subject. The quan-
tity of test substance responsible for the carcinogenic
response is an inherent aspect of the process of risk
assessment. There are two phases of evaluating dose
response in the contemporary approach to risk assess-
ment: dose-range extrapolation and dose scaling. Dose-
range extrapolation involves the estimation oflow doses
and their effects from high-dose exposures based on
mathematical models of the dose-response function.
Dose scaling is the process of interspecies conversion
of dose-response data to equipotent doses for humans.
Regulatory agencies have adopted several different
strategies for interspecies dose scaling. As examples,
the U.S. Environmental ProtectionAgency (EPA) com-
putes the human equipotent dose in proportion to the
0.67 power of body mass, while the Food and Drug
Administration (FDA) usesthefirstpowerofbodymass
forcomputations ofpermissible intakes offood additives
and a constant fraction in the diet for permissible con-
centrations of residues in food.
Numerous investigators, publications, and symposia
have explored mathematical-statistical models from
which dose-range extrapolations ofcarcinogenicriskare
derived. In contrast, little has been published on the
subject of dose scaling of carcinogenic potency. In ad-
dition, there have been few comprehensive reviews on
the principles, applications, or limitations of dose scal-
ing. The increasing use of alternative test systems in
applied toxicology and findings from alternative ap-
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proaches such as molecular genetics and pharmacoki-
netics present the need forredefiningcriteriaforscaling
carcinogenic potency. Regulatory agencies arebeingre-
quired to evaluate information that is either nontradi-
tional (e.g., data from studies of tissue cultures and
isolated genetic material) or conflicting (e.g., data in-
dicating different effects from alternate animal models
and/or from animal models and cellular systems). The
merits ofintegrating alternative approaches to risk as-
sessment in regulatory practice will require continuing
evaluation.
The Life Sciences Research Office, Federation of
American Societies for Experimental Biology, under a
contract from the Center for Food Safety and Applied
Nutrition, FDA, prepared a comprehensive review and
assessment of biological bases for interspecies extrap-
olation of carcinogenicity data (1). The papers in this
volume of Environmental Health Perspectives are a
compilation of manuscripts presented at a symposium
on January 6, 1986, in Bethesda, Maryland.
Members of the ad hoc Panel on Interspecies Ex-
trapolation ofCarcinogenicity Data met twice to obtain
background information, review data analyses, and dis-
cuss related subjects. Authors ofthe symposium manu-
scripts and members of the ad hoc Panel reviewed in-
terim drafts of these papers and provided additional
documentation and viewpoints forincorporationintothe
symposium proceedings.
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